12.30
                                            Schlusskurs vom Vortag:
              $12.15
            Offen:
              $12.16
            24-Stunden-Volumen:
                784.01K
            Relative Volume:
              3.01
            Marktkapitalisierung:
                $150.74M
            Einnahmen:
              $1.54M
            Nettoeinkommen (Verlust:
              $-38.70M
            KGV:
              -2.6338
            EPS:
                -4.67
            Netto-Cashflow:
                $-36.86M
            1W Leistung:
              -27.69%
            1M Leistung:
              -17.06%
            6M Leistung:
                +57.89%
            1J Leistung:
              -27.30%
            Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Firmenname
                  
                      Corbus Pharmaceuticals Holdings Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      617-963-0103
                    
                Adresse
                  
                      500 RIVER RIDGE DRIVE, NORWOOD, MA
                    
                Vergleichen Sie CRBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CRBP
                            
                             
                        Corbus Pharmaceuticals Holdings Inc 
                           | 
                    12.30 | 148.90M | 1.54M | -38.70M | -36.86M | -4.67 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-07-30 | Fortgesetzt | B. Riley Securities | Buy | 
| 2025-02-28 | Eingeleitet | William Blair | Outperform | 
| 2024-12-02 | Eingeleitet | Piper Sandler | Overweight | 
| 2024-07-30 | Eingeleitet | Wedbush | Outperform | 
| 2024-07-22 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2024-06-26 | Eingeleitet | B. Riley Securities | Buy | 
| 2024-06-03 | Bestätigt | Oppenheimer | Outperform | 
| 2024-05-13 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2024-03-06 | Hochstufung | Jefferies | Hold → Buy | 
| 2020-09-08 | Herabstufung | BTIG Research | Buy → Neutral | 
| 2020-09-08 | Herabstufung | Jefferies | Buy → Hold | 
| 2020-09-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform | 
| 2020-09-08 | Herabstufung | ROTH Capital | Buy → Neutral | 
| 2020-07-07 | Eingeleitet | ROTH Capital | Buy | 
| 2020-06-17 | Eingeleitet | BTIG Research | Buy | 
| 2020-03-26 | Eingeleitet | Nomura | Buy | 
| 2019-04-05 | Eingeleitet | Jefferies | Buy | 
| 2019-03-20 | Eingeleitet | Oppenheimer | Outperform | 
| 2019-01-11 | Bestätigt | Cantor Fitzgerald | Overweight | 
| 2018-12-26 | Eingeleitet | H.C. Wainwright | Buy | 
| 2018-12-07 | Eingeleitet | RBC Capital Mkts | Outperform | 
| 2018-10-24 | Eingeleitet | B. Riley FBR | Buy | 
| 2018-01-19 | Eingeleitet | Raymond James | Outperform | 
| 2017-12-14 | Bestätigt | Cantor Fitzgerald | Overweight | 
| 2017-11-08 | Bestätigt | Noble Financial | Buy | 
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy | 
| 2017-03-30 | Bestätigt | Cantor Fitzgerald | Overweight | 
| 2016-11-15 | Bestätigt | JMP Securities | Mkt Outperform | 
| 2016-11-11 | Bestätigt | Noble Financial | Buy | 
                    Alle ansehen
                    
                  
                Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten
What analyst consensus says on Corbus Pharmaceuticals Holdings Inc. stockQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com
Published on: 2025-11-04 00:52:02 - newser.com
Is it time to cut losses on Corbus Pharmaceuticals Holdings Inc.July 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
Published on: 2025-11-03 22:12:54 - newser.com
Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.71 a shareEarnings Preview - TradingView
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidateMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
Corbus Pharmaceuticals Announces $70.5M Public Offering - TipRanks
Form 424B5 Corbus Pharmaceuticals - StreetInsider
Is Corbus Pharmaceuticals Holdings Inc. stock a contrarian buyPortfolio Performance Report & AI Forecasted Entry/Exit Points - newser.com
Published on: 2025-11-03 05:13:38 - newser.com
Published on: 2025-11-03 05:07:17 - newser.com
Quantitative breakdown of Corbus Pharmaceuticals Holdings Inc. recent move2025 Top Gainers & High Yield Stock Recommendations - newser.com
Understanding Corbus Pharmaceuticals Holdings Inc.’s price movement2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Will breakout in Corbus Pharmaceuticals Holdings Inc. lead to full recoveryJuly 2025 Final Week & Pattern Based Trade Signal System - newser.com
AlphaQuest LLC Has $218,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. $CRBP - MarketBeat
How institutional buying supports Corbus Pharmaceuticals Holdings Inc. stockEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock remain on Wall Street radarMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Short interest data insights for Corbus Pharmaceuticals Holdings Inc.Earnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock reach $100 price targetIPO Watch & Low Drawdown Investment Strategies - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsWeekly Profit Analysis & Technical Buy Zone Confirmations - newser.com
Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. losses2025 Support & Resistance & Stock Market Timing Techniques - newser.com
How to build a dashboard for Corbus Pharmaceuticals Holdings Inc. stockOil Prices & Growth Focused Stock Reports - newser.com
Corbus Pharmaceuticals slumps 17%, prices $75M at $13 per share - MSN
Published on: 2025-11-02 11:47:57 - newser.com
Published on: 2025-11-02 07:07:31 - newser.com
Comparing Corbus Pharmaceuticals Holdings Inc. in custom built stock radarsMarket Growth Report & Reliable Entry Point Trade Alerts - newser.com
Published on: 2025-11-01 11:30:29 - newser.com
Published on: 2025-11-01 08:40:29 - newser.com
Corbus Pharmaceuticals provides preliminary Q3 cash estimate in SEC filing By Investing.com - Investing.com Australia
Corbus prices $75 million public offering of common stock By Investing.com - Investing.com Philippines
Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP) - Seeking Alpha
Corbus Pharmaceuticals stock plunges after $75 million public offering By Investing.com - Investing.com UK
Corbus Pharmaceuticals stock plunges after $75 million public offering - Investing.com
Corbus Pharmaceuticals announces common stock offering By Investing.com - Investing.com Australia
Corbus Pharmaceuticals (NASDAQ:CRBP) Share Price Passes Above 50-Day Moving AverageShould You Sell? - MarketBeat
Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Corbus Pharmaceuticals (CRBP) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Published on: 2025-10-31 05:15:03 - newser.com
Published on: 2025-10-31 05:14:27 - newser.com
Corbus Pharmaceuticals Prices $75 Million Offering; Shares Down Pre-Bell - MarketScreener
Corbus prices $75 million public offering of common stock - Investing.com
Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):